PENTAPRAZOLE SODIUM

Penthienate bromide is an anticholinergic antispasmodic that blocks muscarinic receptors in the gastrointestinal tract, reducing motility and spasm. It is used to relieve abdominal cramping and irritable bowel symptoms. Side effects include dry mouth, blurred vision, urinary retention, constipation, and tachycardia, particularly at higher doses or in sensitive individuals. Only GMP materials will be supplied, logistics all according to GDP.

SKU: d6606f032fc4 Category: Tag:

Product Description


Mechanism of Action

PENTAPRAZOLE SODIUM demonstrates a multidimensional biochemical activity pattern, affecting enzymeregulated catalytic networks, receptormediated intracellular signalling, mitochondrial respiratory pathways, oxidativestress regulation, ionchannel behaviour, cytoskeletal mechanics and transcriptionfactor network modulation. Structural evidence suggests potential interactions with catalytic residues, allosteric domains, transmembrane protein complexes, regulatory scaffolds and intracellular signalling intermediates. These interactions allow PENTAPRAZOLE SODIUM to influence phosphorylation kinetics, secondmessenger signalling (Ca²⁺, cAMP, IP, DAG), redoxbuffering systems, ATP turnover rates and mitochondrial membranepotential stability.

Depending on experimental conditions, PENTAPRAZOLE SODIUM may alter metabolic flux distribution, cytoskeletal tension, vesicular transport efficiency, chromatinaccessibility patterns and geneexpression networks related to stress responses, inflammation, apoptosis, autophagy and metabolic adaptation.

Benefits and Advantages

This compound is widely used across highresolution biochemical and pharmacological research areas, including:

  • Receptorligand interaction analysis and affinitymapping
  • Detailed enzymekinetics profiling and catalyticpathway evaluation
  • Mitochondrialdynamics studies, ATPflux modelling and oxidativestress research
  • Integrated multiomics applications (transcriptomics, metabolomics, proteomics, phosphoproteomics)
  • Cytoskeletal and membranemechanics modelling
  • Apoptosis, necroptosis, ferroptosis and autophagy signalling pathway studies
  • SAR (structureactivity relationship) and molecularoptimisation pipelines
  • Mechanistic pharmacodynamic modelling and thresholdactivation experiments

Side Effects and Risks

Laboratoryobserved risks include:

  • Oxidativestress imbalance and ROS overproduction
  • Mitochondrial overload or suppression of respiratorychain complexes
  • Dysregulation of Na⁺/K⁺/Ca²⁺ transport and ionchannel behaviour
  • Unintended receptor crosstalk or inhibitory interference
  • Cytoskeletal destabilisation and membrane-integrity compromise
  • Dosedependent cytotoxicity leading to apoptosis or autophagy
  • Transcriptional instability or inflammatory signalling activation (NF-κB, JNK, MAPK)

Use exclusively under controlled laboratory conditions with strict biosafety procedures.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C16H14F2N4Na2O4S

Molecular Weight

452.36 g/mol

CAS Number

137234-62-9

Storage Condition

Store at 2-8°C

Solubility

Soluble in water

Purity

Purity information is available upon request (COA).

Synonym

Voriconazole; 137234-62-9; Vfend; (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol; UK-109496

IUPAC/Chemical Name

Sodium 6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H€‘benzimidazole€‘1-ide

InChl Key

Unavailable

InChl Code

Unavailable

References

PubChem; ChemBL; FDA;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download